跳至主要内容
临床试验/JPRN-UMIN000026926
JPRN-UMIN000026926已完成未知

A study to evaluate the effect of wood creosote on intestinal flora - A study to evaluate the effect of wood creosote on intestinal flora

Taiko Pharmaceutical Co., Ltd.0 个研究点目标入组 10 人开始时间: 2017年4月28日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
10

研究概览

简要总结

o decrease of the number of intestinal bacteria was confirmed when regular-dose wood creosote was administered. Based upon this result, it is concluded that intestinal bacteria are not killed by the administration of regular-dose wood creosote.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 50years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Subjects who have a disease under treatment 2.Subjects who have diarrhea with fever, bloody stool or continued mucus stool 3.Pregnant and lactating female, or subjects who are judged as pregnant 4.Subjects who have hypersensitivity or idiosyncrasy to drugs, in particular wood creosote, or those with a history of that 5.Subjects with constipation or diarrhea 6.Subjects who have more drinking habits than the appropriate range and excessive smoking habits 7.Subjects who used or took a medicine within one week before the first day of the study or those who need to use or take a medicine 8.Subjects who take foods for specified health uses , foods with function claims and foods with nutrient function claims (supplements in capsule form and others), excluding those who can stop taking those foods after informed consent) 9.Shift workers during the night 10.Subjects who cannot regularly consume three meals in the morning, noon, and evening, every day 11.Subjects who are planning to travel both domestically and abroad for one week before the first day of the study or during the study period 12.Subjects who cannot participate in the screening test and the study period (7 days), or who cannot visit on the prescribed date 13.Subjects who are unable to fill in their daily diaries during the prescribed period 14.Subjects who donated more than 200 mL of blood within one month before the first day of the study or subjects who have the schedule during the study period 15.Subjects who participated in other clinical trials within 12 weeks before the first day of the study and received medication 16.Subjects who are judged as ineligible to participate in the study for other reasons by the principal investigator

研究者

相似试验